Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Applied Molecular Transport stock | $30.59

Own Applied Molecular Transport stock in just a few minutes.

Fact checked

Applied Molecular Transport Inc is a biotechnology business based in the US. Applied Molecular Transport shares (AMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Molecular Transport employs 64 staff and has a market cap (total outstanding shares value) of USD$1.2 billion.

How to buy shares in Applied Molecular Transport

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Applied Molecular Transport. Find the stock by name or ticker symbol: AMTI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Applied Molecular Transport reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$30.59, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Applied Molecular Transport, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Applied Molecular Transport. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Applied Molecular Transport share price

Use our graph to track the performance of AMTI stocks over time.

Applied Molecular Transport shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$30.59
52-week rangeUSD$17.045 - USD$36.21
50-day moving average USD$31.2873
200-day moving average USD$27.8077
Wall St. target priceUSD$34.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.2214

Buy Applied Molecular Transport shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Applied Molecular Transport stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Molecular Transport price performance over time

Historical closes compared with the close of $30.59 from 2020-12-09

1 week (2021-01-07) -9.42%
1 month (2020-12-17) -8.25%
3 months (2020-10-15) -5.70%
6 months (2020-07-15) 49.07%
1 year (2020-01-13) N/A
2 years (2019-01-13) N/A
3 years (2018-01-13) N/A
5 years (2016-01-13) N/A

Applied Molecular Transport financials

Gross profit TTM USD$-14,228,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation USD$1.2 billion

TTM: trailing 12 months

Shorting Applied Molecular Transport shares

There are currently 1.5 million Applied Molecular Transport shares held short by investors – that's known as Applied Molecular Transport's "short interest". This figure is 10.5% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Applied Molecular Transport shares can be evaluated.

Applied Molecular Transport's "short interest ratio" (SIR)

Applied Molecular Transport's "short interest ratio" (SIR) is the quantity of Applied Molecular Transport shares currently shorted divided by the average quantity of Applied Molecular Transport shares traded daily (recently around 125493.94435352). Applied Molecular Transport's SIR currently stands at 12.22. In other words for every 100,000 Applied Molecular Transport shares traded daily on the market, roughly 12220 shares are currently held short.

However Applied Molecular Transport's short interest can also be evaluated against the total number of Applied Molecular Transport shares, or, against the total number of tradable Applied Molecular Transport shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Applied Molecular Transport's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Applied Molecular Transport shares in existence, roughly 50 shares are currently held short) or 0.1059% of the tradable shares (for every 100,000 tradable Applied Molecular Transport shares, roughly 106 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Applied Molecular Transport.

Find out more about how you can short Applied Molecular Transport stock.

Applied Molecular Transport share dividends

We're not expecting Applied Molecular Transport to pay a dividend over the next 12 months.

Applied Molecular Transport overview

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its lead product candidate is AMT-101, an oral gastrointestinal (GI) selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The company, through its technology platform designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and RNA therapeutics. In addition, it engages in the development of AMT-126, a GI-selective oral fusion of rhIL-22 for diseases related to intestinal epithelium barrier function defects. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site